Introduction
In the abdomen of mammals, brown and white adipose tissues (BAT and WAT, respectively) are distinctly located and have different, complementary functions: BAT is predominantly found in the perirenal tissue and mobilizes accumulated energy (e.g. heat) in response to noradrenergic stimulation; WAT occupies the inguinal tissue and mobilizes lipid reservoirs in response to metabolic needs between meals. 1, 2 There is adequate evidence of a regulatory role of BAT on WAT, as demonstrated by genetic studies in which impaired BAT activity has been associated with obesity, hyperlipidemia, and insulin resistance. 3 Weight gain is a common side effect of lithium therapy in humans, 4 but the mechanisms of this effect are not well established. 5 Cell-culture studies with adipocyte precursors demonstrate an inhibitory effect of lithium on the differentiation of white 6 and brown 7 adipocytes. The aims of the present study were: 1) to evaluate whether the administration of lithium to adult rats is able to independently modify perirenal (BAT) and inguinal (WAT) tissues; 2) because BAT is under noradrenergic control, 8 to assess whether methylphenidate (MPH), a dopaminergic and noradrenergic drug, is able to modulate lithium effects. MPH was chosen because attention-defi cit and hyperactivity have recently been recognized as frequent comorbidities in bipolar patients, 9 and the coprescription of both drugs (lithium and MPH) is becoming common in clinical practice.
Methods
Twenty-fi ve adult male Wistar rats, 90-120 days old, weighing 160-220 g, were used in the study. Animals were fed with either regular (10 rats) or lithium-containing (15 rats) chow, at 2.5 mg LiCl + 17 mg NaCl/g of chow, as described previously, 10 for 30 days. The lithium treatment delivered leads to serum levels between 0.4 and 1.2 mEq/l.
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Between days 15 to 30 of treatment, all animals in both groups received daily intraperitoneal administrations of a solution containing either MPH at 5 mg/kg (13 rats, of which eight had received lithium) or saline solution (12 rats, of which seven had received lithium), a regimen frequently employed in experiments performed with rats. 12, 13 On the 30th day of treatment, animals were decapitated, and perirenal and inguinal fat pads were dissected and weighed, using a scale with a precision of 0.0001 g.
All treatments were in accordance with the guidelines of the institution where the study was carried out and followed the principles and recommendations of laboratory animal care. Data were analyzed using two-way analysis of variance (ANOVA), and results were expressed as mean ± standard error of the mean (SEM). 
Results

Lithium administration decreased animal weight
Discussion
Our study showed that 30 days of lithium treatment reduced total and perirenal fat and that this effect was counterbalanced by MPH administration. To our knowledge, no other studies have so far been designed to evaluate the effects of lithium on perirenal and inguinal fat in vivo.
Previous studies with cell cultures have shown that lithium inhibits adipocyte differentiation: inducer-stimulated adipose conversion of 3T3-L1 cells was inhibited by lithium in mouse preadipocyte models, 6 as was the expression of mRNAs for UCP-1, PG-1 alpha, and PPAR-alpha, genes that are specifi c to differentiated brown tissue. 7 The process seems to occur via inhibition of GSK-3β, and hence, indirectly, enhancement of transmission via the Wnt signaling pathway. 14, 15 A reduction in BAT may be explained by decreased synthesis or increased degradation of triacylglycerol depots. BAT stimulation occurs mainly via beta-adrenergic receptors and the cAMP signal transduction pathway, and there are well documented effects of lithium on the noradrenaline pool, on the expression of adrenoceptors, on Gs-and Gi-proteins, and on adenyl cyclase function. 5, 16 This may, at least in part, explain our results. Also, lithium-related inhibition of GSK-β and the consequent enhancement of Wnt signaling may underlie the effects herein observed on fat stores.
The counterbalance provided by MPH against the effects of lithium is in accordance with the already known noradrenergic stimulation of BAT. MPH inhibits noradrenaline and dopamine transporters at a K I of 0.17 ± 0.03 and 0.26 ± 0.03 mcM, respectively. 17 The administration of noradrenaline to cells whose differentiation was inhibited by 5 mM of lithium as of the 4th day of culture has led to UCP-1 mRNA expression, a characteristic of active BAT. 7 However, although our results are in accordance with the reported literature, some relevant considerations should be made. First, treatment effect sizes in this study were small, and data should be analyzed under this perspective. Second, the effects on cell differentiation observed in cell cultures are not the same observed in adult tissues. In fact, a previous study has described that, on the seventh day of culture, when cells are already differentiated, lithium treatment does not modify cells. 7 The inhibitory effect of lithium on cell differentiation and also, according to our results, on fat mass (BAT in particular) seems to be a paradox in light of the known weight gain associated with lithium treatment in humans. There are some possible explanations to this fi nding. First, in great mammals, including humans, the amount of BAT decreases importantly after birth, whereas in rodents it persists throughout life 1 ; this may contribute to inter-species differences in terms of BAT/WAT regulation and lithium treatment effects. Second, it is possible that differences in the texture or palatability of the chows administered to rats have modifi ed consumption patterns, although a previous experiment using normal chow prepared with NaCl in the same concentrations used in the present study did not affect consumption (Vasconcellos APS, personal communication), and another study by the same group of authors currently under development performed with animals receiving the same lithium-containing chow reported that these animals ate more normal chow and highcaloric foods when compared with controls. Also, genetic manipulations in which BAT features are underexpressed have been found to cause obesity and insulin resistance. 18 Because obesity does not occur suddenly, it is possible that differences in inguinal fat would be observed had the animals been followed over a longer period. This long-term assessment, however, is a matter for future studies.
